Cable Hill Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Cable Hill Partners’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-73	Closed	-$3K	–	782
2019 Q1	$3K	Buy	+73	New	+$3.35K	﹤0.01%	728
2018 Q1	–	Sell	-200	Closed	-$8K	–	980
2017 Q4	$8K	Hold	200	–	–	﹤0.01%	633
2017 Q3	$5K	Hold	200	–	–	﹤0.01%	786
2017 Q2	$3K	Hold	200	–	–	﹤0.01%	653
2017 Q1	$3K	Hold	200	–	–	﹤0.01%	645
2016 Q4	$3K	Hold	200	–	–	﹤0.01%	631
2016 Q3	$4K	Hold	200	–	–	﹤0.01%	637
2016 Q2	$4K	Hold	200	–	–	﹤0.01%	568
2016 Q1	$4K	Hold	200	–	–	﹤0.01%	528
2015 Q4	$4K	Hold	200	–	–	﹤0.01%	517
2015 Q3	$4K	Buy	+200	New	+$6.79K	﹤0.01%	555

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Cable Hill Partners's ARNA Position: Q2 2019 in Review

Cable Hill Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2019, closing a stake of 73 shares — an estimated $3K sold.

Cable Hill Partners first reported a position in ARNA in Q3 2015 and held it in 11 quarters. The position peaked at $8K in Q4 2017. 215 funds tracked by Wall St. Rank hold ARNA as of Q2 2019.

Cable Hill Partners reported no remaining Arena Pharmaceuticals Inc position as of Q2 2019 after selling out during the quarter.
Cable Hill Partners sold 73 Arena Pharmaceuticals Inc shares in Q2 2019, an estimated $3K.
Cable Hill Partners first reported a position in Arena Pharmaceuticals Inc in Q3 2015 and held it in 11 quarters.
Cable Hill Partners's Arena Pharmaceuticals Inc position peaked at $8K in Q4 2017.
215 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2019.

Based on Cable Hill Partners's 13F filing for Q2 2019, filed 6 Aug 2019.